Related Experiment Video

Updated: Aug 25, 2026

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

[21 hydroxylase deficiency: new strategies emerging from molecular studies]

Y Morel1, V Tardy, J-M Costa

  • 1Laboratoire de biochimie endocrinienne et moléculaire, hôpital Debrousse, 69322 Lyon Cedex 05 et EA 3739, université Claude Bernard-Lyon I.

Annales D'Endocrinologie
|April 7, 2004
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...